UCB to acquire Ra Pharmaceuticals in $2.1 billion deal
October 10, 2019 at 02:28 AM EDT
Shareholders of Ra Pharma will receive $48 for each share held, a joint statement by the two companies said Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|